| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.68M | $71.94M | - | |
| 10% | 3.14M | $61.38M | - | |
| Other | 1.81M | $35.35M | - | |
| Other | 1.79M | $35.09M | - | |
| VP | 200.1K | $3.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 19,426 | $8.69 | $168,725.08 | +0.3% | -19.9% | +66.1% | |
| Aug 11, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 19,669 | $8.40 | $165,219.60 | +0.7% | -17.3% | +79.3% | |
| Jun 29, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 4,000 | $11.64 | $46,540.00 | - | -36.7% | +38.0% | |
| Jun 24, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 700 | $12.09 | $8,462.00 | - | -32.0% | +47.5% | |
| May 27, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,000 | $15.82 | $15,820.00 | - | -45.7% | +12.1% | |
| May 20, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 300 | $16.54 | $4,962.00 | - | -43.3% | +9.6% | |
| May 20, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,200 | $16.73 | $20,070.00 | - | -43.3% | +9.6% | |
| May 18, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 2,010 | $19.48 | $39,155.30 | - | -51.4% | -10.7% | |
| May 17, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 242 | $19.44 | $4,704.10 | - | -54.5% | -16.8% | |
| May 16, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,700 | $18.82 | $31,990.00 | - | -51.1% | -11.1% |